Related references
Note: Only part of the references are listed.Loss of KDM6A Activates Super-Enhancers to Induce Gender-Specific Squamous-like Pancreatic Cancer and Confers Sensitivity to BET Inhibitors
Jaclyn Andricovich et al.
CANCER CELL (2018)
Evolution of Cytogenetically Normal Acute Myeloid Leukemia During Therapy and Relapse: An Exome Sequencing Study of 50 Patients
Philipp A. Greif et al.
CLINICAL CANCER RESEARCH (2018)
MLL4 Is Required to Maintain Broad H3K4me3 Peaks and Super-Enhancers at Tumor Suppressor Genes
Shilpa S. Dhar et al.
MOLECULAR CELL (2018)
UTX-mediated enhancer and chromatin remodeling suppresses myeloid leukemogenesis through noncatalytic inverse regulation of ETS and GATA programs
Malgorzata Gozdecka et al.
NATURE GENETICS (2018)
UTX is an escape from X-inactivation tumor-suppressor in B cell lymphoma
Xiaoxi Li et al.
NATURE COMMUNICATIONS (2018)
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
Hartmut Doehner et al.
BLOOD (2017)
Histone H3 lysine 4 methyltransferase KMT2D
Eugene Froimchuk et al.
GENE (2017)
Loss of tumor suppressor KDM6A amplifies PRC2-regulated transcriptional repression in bladder cancer and can be targeted through inhibition of EZH2
Lian Dee Ler et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Resistance of leukemia cells to cytarabine chemotherapy is mediated by bone marrow stroma, involves cell-surface equilibrative nucleoside transporter-1 removal and correlates with patient outcome
Patricia Macanas-Pirard et al.
ONCOTARGET (2017)
SLC29A1 (ENT1) polymorphisms and outcome of complete remission in acute myeloid leukemia
Jeong-Hyun Kim et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)
The Spectrum and Clinical Impact of Epigenetic Modifier Mutations in Myeloma
Charlotte Pawlyn et al.
CLINICAL CANCER RESEARCH (2016)
Genomic Classification and Prognosis in Acute Myeloid Leukemia
Elli Papaemmanuil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Genomic characterization of pediatric T-cell acute lymphoblastic leukemia reveals novel recurrent driver mutations
Jean-Franois Spinella et al.
ONCOTARGET (2016)
Genomic Profiling of Advanced-Stage, Metaplastic Breast Carcinoma by Next-Generation Sequencing Reveals Frequent, Targetable Genomic Abnormalities and Potential New Treatment Options
Jeffrey S. Ross et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2015)
IBS: an illustrator for the presentation and visualization of biological sequences
Wenzhong Liu et al.
BIOINFORMATICS (2015)
Acute Myeloid Leukemia
Hartmut Doehner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Nucleoside transporter proteins as biomarkers of drug responsiveness and drug targets
Marcal Pastor-Anglada et al.
FRONTIERS IN PHARMACOLOGY (2015)
Characterization of gene mutations and copy number changes in acute myeloid leukemia using a rapid target enrichment protocol
Niccolo Bolli et al.
HAEMATOLOGICA (2015)
An Advanced Preclinical Mouse Model for Acute Myeloid Leukemia Using Patients' Cells of Various Genetic Subgroups and In Vivo Bioluminescence Imaging
Binje Vick et al.
PLOS ONE (2015)
Induction of aldo-keto reductases (AKR1C1 and AKR1C3) abolishes the efficacy of daunorubicin chemotherapy for leukemic U937 cells
Toshiyuki Matsunaga et al.
ANTI-CANCER DRUGS (2014)
Concurrent Alterations in TERT, KDM6A, and the BRCA Pathway in Bladder Cancer
Michael L. Nickerson et al.
CLINICAL CANCER RESEARCH (2014)
SLC29A1 single nucleotide polymorphisms as independent prognostic predictors for survival of patients with acute myeloid leukemia: an in vitro study
Haixia Wan et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2014)
Contrasting roles of histone 3 lysine 27 demethylases in acute lymphoblastic leukaemia
Panagiotis Ntziachristos et al.
NATURE (2014)
The landscape of somatic mutations in epigenetic regulators across 1,000 paediatric cancer genomes
Robert Huether et al.
NATURE COMMUNICATIONS (2014)
The MLL3/MLL4 Branches of the COMPASS Family Function as Major Histone H3K4 Monomethylases at Enhancers
Deqing Hu et al.
MOLECULAR AND CELLULAR BIOLOGY (2013)
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
Timothy J. Ley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
UTX regulates mesoderm differentiation of embryonic stem cells independent of H3K27 demethylase activity
Chaochen Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
DNA Methylation Signatures Identify Biologically Distinct Subtypes in Acute Myeloid Leukemia
Maria E. Figueroa et al.
CANCER CELL (2010)
Characterization of an antagonistic switch between histone H3 lysine 27 methylation and acetylation in the transcriptional regulation of Polycomb group target genes
Diego Pasini et al.
NUCLEIC ACIDS RESEARCH (2010)
Histone H3K27ac separates active from poised enhancers and predicts developmental state
Menno P. Creyghton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer
Gijs van Haaften et al.
NATURE GENETICS (2009)
Identification of JmjC domain-containing UTX and JMJD3 as histone H3 lysine 27 demethylases
SunHwa Hong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Demethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination
Min Gyu Lee et al.
SCIENCE (2007)
UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development
Karl Agger et al.
NATURE (2007)
Share Paper
